{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:16:25Z","timestamp":1788261385280,"version":"build-2803163510"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"EDCTP Career Development Fellowship","award":["TMA2018CDF-2398"],"award-info":[{"award-number":["TMA2018CDF-2398"]}]},{"DOI":"10.13039\/501100001665","name":"French Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020558","name":"Laboratoire d\u2019Excellence (LabEx) \u2018French Parasitology Alliance for Health Care\u2019","doi-asserted-by":"publisher","award":["ANR-11-15 LABX-0024-PARAFRAP"],"award-info":[{"award-number":["ANR-11-15 LABX-0024-PARAFRAP"]}],"id":[{"id":"10.13039\/100020558","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003768","name":"University of Strasbourg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003768","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004417","name":"Global Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004417","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Molecular surveillance is essential to detect emerging artemisinin partial resistance (ART-R) and partner drug resistance in Sub-Saharan Africa.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To describe the prevalence of Plasmodium falciparum resistance markers in two high-burden countries using artesunate-amodiaquine (ASAQ) and artemether-lumefantrine (AL): the Democratic Republic of the Congo (DRC) and Tanzania.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 1254 day-0 P. falciparum-positive samples were analysed: 837 from four sentinel sites of a therapeutic efficacy study (TES) in the DRC (2017) and 417 from an intermittent preventive treatment in schoolchildren (IPTsc) trial in Handeni and Kilindi districts, Tanga Region, Tanzania (2020\u20132021). Pfkelch13, Pfcrt and Pfmdr1 were analysed by Illumina MiSeq amplicon sequencing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Reliable sequences were obtained for 1193 isolates. The Pfkelch13 wild-type allele predominated (98.4%); none of the four non-synonymous mutations detected (N489Y, K568T, A578S, V589I) are classified as validated, candidate or potential ART-R markers, and the validated markers R561H, P441L and C469Y reported elsewhere in East Africa were absent. Pfcrt K76T was found in 23.3% of Tanzanian and 26.3% of DRC isolates, with substantial between-site variation in the DRC (4.3% to 93.6% at Rutshuru). Pfmdr1 haplotype profiles differed between countries: NFSND predominated in Tanzania (71.5%) while NYSND remained the most frequent in the DRC (60.9%); 86Y was twice as frequent in the DRC (11.1%) as in Tanzania (6.2%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>No validated ART-R marker was detected, but partner-drug haplotype distributions reflected the first-line ACTs used in each country. Continued molecular surveillance is needed to track these signatures alongside the recent emergence of ART-R.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jac\/dkag309","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:44:38Z","timestamp":1787312678000},"source":"Crossref","is-referenced-by-count":0,"title":["Genomic profiling of drug resistance markers in\n                    <i>Plasmodium falciparum<\/i>\n                    samples from the Democratic Republic of the Congo (2017) and Tanzania (2020\u20132021)"],"prefix":"10.1093","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7507-7075","authenticated-orcid":false,"given":"Flory Luzolo","family":"Khote","sequence":"first","affiliation":[{"name":"Department of Tropical Medicine, University of Kinshasa , Kinshasa , Democratic Republic of the","place":["Congo"]},{"name":"Global Health Institute, University of Antwerp , Antwerp ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hypolite","family":"Muhindo Mavoko","sequence":"additional","affiliation":[{"name":"Department of Tropical Medicine, University of Kinshasa , Kinshasa , Democratic Republic of the","place":["Congo"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Mitashi","sequence":"additional","affiliation":[{"name":"Department of Tropical Medicine, University of Kinshasa , Kinshasa , Democratic Republic of the","place":["Congo"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Papy","family":"Mandoko","sequence":"additional","affiliation":[{"name":"Institut National des Recherches Biom\u00e9dicales (INRB) Departement de parasitologie, , Kinshasa , Republique D\u00e9mocratique du","place":["Congo"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Destin","family":"Mbongi","sequence":"additional","affiliation":[{"name":"Centre Hospitalier Monkole , Kinshasa , Democratic Republic of the","place":["Congo"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geofrey","family":"Makenga","sequence":"additional","affiliation":[{"name":"Global Health Institute, University of Antwerp , Antwerp ,","place":["Belgium"]},{"name":"National Institute for Medical Research , Tanga ,","place":["Tanzania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel T R","family":"Minja","sequence":"additional","affiliation":[{"name":"National Institute for Medical Research , Tanga ,","place":["Tanzania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filbert","family":"Francis","sequence":"additional","affiliation":[{"name":"National Institute for Medical Research , Tanga ,","place":["Tanzania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reginald","family":"Kavishe","sequence":"additional","affiliation":[{"name":"Kilimanjaro Clinical Research Institute (KCRI), Kilimanjaro Christian Medical University College (KCMUCo), Tumaini University Makumira , Moshi ,","place":["Tanzania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"van Geertruyden","sequence":"additional","affiliation":[{"name":"Global Health Institute, University of Antwerp , Antwerp ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gauthier Mesia","family":"Kahunu","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, University of Kinshasa , Kinshasa , Democratic Republic of the","place":["Congo"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Menard","sequence":"additional","affiliation":[{"name":"Malaria Genetics and Resistance Team (MEGATEAM), UR 3073\u2014Pathogens Host Arthropods Vectors Interactions Unit, Universit\u00e9 de Strasbourg , Strasbourg F-67000 ,","place":["France"]},{"name":"Malaria Parasite Biology and Vaccines, INSERM Unit 1347\u2014ParasitInnov, Institut Pasteur, Universit\u00e9 Paris Cit\u00e9 , Paris F-75015 ,","place":["France"]},{"name":"Laboratory of Parasitology and Medical Mycology, CHU Strasbourg , Strasbourg F-67000 ,","place":["France"]},{"name":"Institut Universitaire de France (IUF) , Paris F-75231 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito","family":"Baraka","sequence":"additional","affiliation":[{"name":"National Institute for Medical Research , Tanga ,","place":["Tanzania"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"key":"2026090106295115100_dkag309-B1","author":"WHO"},{"key":"2026090106295115100_dkag309-B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a025619","article-title":"Antimalarial drug resistance: a threat to malaria elimination","volume":"7","author":"Menard","year":"2017","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2026090106295115100_dkag309-B3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s40471-021-00266-5","article-title":"Antimalarial drug resistance and implications for the WHO global technical strategy","volume":"8","author":"Ippolito","year":"2021","journal-title":"Curr Epidemiol Rep"},{"key":"2026090106295115100_dkag309-B4","author":"Health Organization W"},{"key":"2026090106295115100_dkag309-B5","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin resistance in plasmodium falciparum malaria","volume":"361","author":"Dondorp","year":"2009","journal-title":"N Engl J Med"},{"key":"2026090106295115100_dkag309-B6","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1038\/s41591-020-1005-2","article-title":"Emergence and clonal expansion of in vitro artemisinin-resistant plasmodium falciparum kelch13 R561H mutant parasites in Rwanda","volume":"26","author":"Uwimana","year":"2020","journal-title":"Nat Med"},{"key":"2026090106295115100_dkag309-B7","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/S1473-3099(21)00142-0","article-title":"Association of plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study","volume":"21","author":"Uwimana","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"2026090106295115100_dkag309-B8","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJMoa2101746","article-title":"Evidence of artemisinin-resistant malaria in Africa","volume":"385","author":"Balikagala","year":"2021","journal-title":"N Engl J Med"},{"key":"2026090106295115100_dkag309-B9","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1056\/NEJMoa2210956","article-title":"Increasing prevalence of artemisinin-resistant HRP2-negative malaria in Eritrea","volume":"389","author":"Mihreteab","year":"2023","journal-title":"N Engl J Med"},{"key":"2026090106295115100_dkag309-B10","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12936-024-04896-0","article-title":"Trends of plasmodium falciparum molecular markers associated with resistance to artemisinins and reduced susceptibility to lumefantrine in mainland Tanzania from 2016 to 2021","volume":"23","author":"Bakari","year":"2024","journal-title":"Malar J"},{"key":"2026090106295115100_dkag309-B11","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/S1473-3099(24)00362-1","article-title":"Evidence of artemisinin partial resistance in northwestern Tanzania: clinical and molecular markers of resistance","volume":"24","author":"Ishengoma","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"2026090106295115100_dkag309-B12","doi-asserted-by":"publisher","first-page":"100920","DOI":"10.1016\/S2666-5247(24)00160-5","article-title":"Prevalence of mutations associated with artemisinin partial resistance and sulfadoxine\u2013pyrimethamine resistance in 13 regions in Tanzania in 2021: a cross-sectional survey","volume":"5","author":"Juliano","year":"2024","journal-title":"Lancet Microbe"},{"key":"2026090106295115100_dkag309-B13","doi-asserted-by":"publisher","first-page":"e66277","DOI":"10.7554\/eLife.66277","article-title":"Plasmodium falciparum K13 mutations in Africa and Asia impact artemisinin resistance and parasite fitness","volume":"10","author":"Stokes","year":"2021","journal-title":"Elife"},{"key":"2026090106295115100_dkag309-B14","author":"Health Organization W"},{"key":"2026090106295115100_dkag309-B15","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1056\/NEJM200101253440403","article-title":"A molecular marker for chloroquine-resistant falciparum malaria","volume":"344","author":"Djimd\u00e9","year":"2001","journal-title":"N Engl J Med"},{"key":"2026090106295115100_dkag309-B16","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.pt.2012.08.002","article-title":"PfCRT and its role in antimalarial drug resistance","volume":"28","author":"Ecker","year":"2012","journal-title":"Trends Parasitol"},{"key":"2026090106295115100_dkag309-B17","doi-asserted-by":"publisher","first-page":"18883","DOI":"10.1073\/pnas.0911317106","article-title":"Geographic patterns of plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquine","volume":"106","author":"S\u00e1","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026090106295115100_dkag309-B18","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1086\/507115","article-title":"Decreasing pfmdr1 copy number in plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin","volume":"194","author":"Sidhu","year":"2006","journal-title":"J Infect Dis"},{"key":"2026090106295115100_dkag309-B19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ijid.2023.11.026","article-title":"Identification of the PfK13 mutations R561H and P441L in the democratic Republic of Congo","volume":"139","author":"Mesia Kahunu","year":"2024","journal-title":"Int J Infect Dis"},{"key":"2026090106295115100_dkag309-B20","doi-asserted-by":"publisher","first-page":"653","DOI":"10.4269\/ajtmh.23-0740","article-title":"Detection of artemisinin resistance marker kelch-13 469Y in plasmodium falciparum, south kivu, democratic republic of the Congo, 2022","volume":"110","author":"van Loon","year":"2024","journal-title":"Am J Trop Med Hyg"},{"key":"2026090106295115100_dkag309-B21","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.4269\/ajtmh.21-0214","article-title":"Therapeutic efficacy of artemisinin-based combination therapies in democratic republic of the Congo and investigation of molecular markers of antimalarial resistance","volume":"105","author":"Moriarty","year":"2021","journal-title":"Am J Trop Med Hyg"},{"key":"2026090106295115100_dkag309-B22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12936-022-04428-8","article-title":"Implementation research of a cluster randomized trial evaluating the implementation and effectiveness of intermittent preventive treatment for malaria using dihydroartemisinin-piperaquine on reducing malaria burden in school-aged children in Tanzania: me\u2026","volume":"22","author":"Makenga","year":"2023","journal-title":"Malar J"},{"key":"2026090106295115100_dkag309-B23","volume-title":"Methods for Surveillance of Antimalarial Drug Efficacy","author":"WHO","year":"2009"},{"key":"2026090106295115100_dkag309-B24","doi-asserted-by":"publisher","first-page":"e0237791","DOI":"10.1371\/journal.pone.0237791","article-title":"The lack of K13-propeller mutations associated with artemisinin resistance in plasmodium falciparum in democratic Republic of Congo (DRC)","volume":"15","author":"Malekita Yobi","year":"2020","journal-title":"PLoS One"},{"key":"2026090106295115100_dkag309-B25","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ijpddr.2021.06.001","article-title":"A review of the frequencies of plasmodium falciparum kelch 13 artemisinin resistance mutations in Africa","volume":"16","author":"Ndwiga","year":"2021","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"2026090106295115100_dkag309-B26","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s12936-026-05929-6","article-title":"Cross-border molecular epidemiology of plasmodium falciparum drug susceptibility: insights from the Uganda\u2013democratic republic of the Congo border","volume":"25","author":"Dilufwasayo","year":"2026","journal-title":"Malar J"},{"key":"2026090106295115100_dkag309-B27","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1093\/infdis\/jiu608","article-title":"K13-propeller polymorphisms in plasmodium falciparum parasites from sub-saharan Africa","volume":"211","author":"Kamau","year":"2015","journal-title":"J Infect Dis"},{"key":"2026090106295115100_dkag309-B28","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s12936-025-05486-4","article-title":"Prevalence of plasmodium falciparum parasites harbouring chloroquine-resistant but not artemisinin-resistant alleles in busia county, western Kenya","volume":"24","author":"Onchieku","year":"2025","journal-title":"Malar J"},{"key":"2026090106295115100_dkag309-B29","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/j.1365-3156.2007.01995.x","article-title":"Chloroquine-resistance molecular markers (pfcrt T76 and pfmdr-1 Y86) and amodiaquine resistance in Burkina Faso","volume":"13","author":"Tinto","year":"2008","journal-title":"Trop Med Int Health"},{"key":"2026090106295115100_dkag309-B30","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/1475-2875-10-304","article-title":"A thirteen-year analysis of plasmodium falciparum populations reveals high conservation of the mutant pfcrt haplotype despite the withdrawal of chloroquine from national treatment guidelines in Gabon","volume":"10","author":"Frank","year":"2011","journal-title":"Malar J"},{"key":"2026090106295115100_dkag309-B31","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12936-021-03636-y","article-title":"Assessment of plasmodium falciparum anti-malarial drug resistance markers in pfk13-propeller, pfcrt and pfmdr1 genes in isolates from treatment failure patients in democratic Republic of Congo, 2018\u20132019","volume":"20","author":"Yobi","year":"2021","journal-title":"Malar J"},{"key":"2026090106295115100_dkag309-B32","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1684\/mst.2019.0925","article-title":"Evaluation of the application of national malaria treatment guidelines in private pharmacies in a rural area in the democratic Republic of Congo","volume":"29","author":"Mandoko","year":"2019","journal-title":"Med Sante Trop"},{"key":"2026090106295115100_dkag309-B33","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.actatropica.2004.09.010","article-title":"Prevalence of pfcrt mutations in Congolese and Malawian plasmodium falciparum isolates as determined by a new taqman assay","volume":"93","author":"Wilson","year":"2005","journal-title":"Acta Trop"},{"key":"2026090106295115100_dkag309-B34","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12936-020-03192-x","article-title":"Molecular surveillance of anti-malarial drug resistance in democratic Republic of Congo: high variability of chloroquinoresistance and lack of amodiaquinoresistance","volume":"19","author":"Yobi","year":"2020","journal-title":"Malar J"},{"key":"2026090106295115100_dkag309-B35","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.1128\/AAC.00358-10","article-title":"Amodiaquine resistance in plasmodium falciparum malaria in Afghanistan is associated with the pfcrt SVMNT allele at codons 72 to 76","volume":"54","author":"Beshir","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"2026090106295115100_dkag309-B36","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1086\/504269","article-title":"Occurrence of the Southeast Asian\/south American SVMNT haplotype of the chloroquine-resistance transporter gene in plasmodium falciparum in Tanzania","volume":"193","author":"Alifrangis","year":"2006","journal-title":"J Infect Dis"},{"key":"2026090106295115100_dkag309-B37","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2018-000999","article-title":"Emerging implications of policies on malaria treatment: genetic changes in the pfmdr-1 gene affecting susceptibility to artemether-lumefantrine and artesunate-amodiaquine in Africa","volume":"3","author":"Okell","year":"2018","journal-title":"BMJ Glob Health"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/81\/10\/dkag309\/70892620\/dkag309.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/81\/10\/dkag309\/70892620\/dkag309.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T10:32:33Z","timestamp":1788258753000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/doi\/10.1093\/jac\/dkag309\/8778363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkag309","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,9,1]]},"article-number":"dkag309"}}